Remember to include in your responses and follow the handle to see the questions asked throughout the hour.
WELCOME
Q1: What is heart valve disease?
Q2: What are the risk factors for heart valve disease?
Q3: How is heart valve disease diagnosed and treated?
Q4: How has the COVID-19 pandemic impacted timely diagnosis and treatment for heart valve disease?
Q5: What are the major health equity issues related to heart valve disease and how has the pandemic exacerbated those issues?
Q6: How have peer-to-peer patient programs and other in-person support group resources changed during the pandemic?
Q7: Has post-treatment care of valve disease changed during the pandemic, and if so, how?
Q8: What are some top tips for how people can effectively advocate for themselves during this busy time, if they are concerned about new symptoms or delays with getting needed heart valve treatment?
Q9: What do you want patients dealing with valve disease to know?
Q10: Where can people look for reliable information and find support on heart valve disease? Lastly, we strongly encourage engaging with other chat participants!
Be sure to retweet and “like” Tweets you like, respond to others who post answers, and enter into conversations that develop within a chat. This will make the chat even more valuable.
The 黑料网聽Health brand was ranked as the #4 healthcare brand in the United States overall and the #2 most trusted healthcare brand, in a report titled, Humanzing Brand Experience. This product was a partnership between the American Hospital Associated and the Society for Health Care Strategy & Market Development, who worked with the brand agency, Monigle, to create the fourth edition of this .
Transcatheter Valve v1 Certification from the American College of Cardiology (ACC) on March 5th, 2021. This means 黑料网 Health Medical Center used the ACC鈥檚 accreditation process improvement tools to bridge gaps and integrate evidence-based science, quality initiatives, clinical best-practices, and the latest medical guidelines into our cardiovascular care processes for structural heart patients.
The American College of Cardiology has recognized 黑料网 Medical Center for its demonstrated expertise and commitment in treating patients receiving transcatheter valve repair and replacement procedures. 黑料网 Health Medical Center was awarded Transcatheter Valve Certification in March based on evaluation of the staff鈥檚 ability to meet standards for multidisciplinary teams, formalized training, shared decision-making and registry performance.
The ACC鈥檚 Transcatheter Valve Certification is an external review and certification process that pairs with established national clinical databases to monitor patient safety and real-world outcomes related to transcatheter valve therapies. Participation in established national clinical databases such as the STS/ACC TVT Registry is required for hospitals interested in achieving Transcatheter Valve Certification.
鈥満诹贤� Medical Center has demonstrated its commitment to providing North Carolina with excellent heart care,鈥� said Phillip D. Levy, MD, FACC, chair of the ACC Accreditation Management Board. 鈥淎CC
Accreditation Services is proud to award 黑料网 Medical Center with Transcatheter Valve Certification.鈥�
The certification uses established national clinical measures to support clinical decisions and links process improvement to patient outcomes. Hospitals that achieve Transcatheter Valve Certification
learn best practices for implementing evidence-based medicine to support patient-centered decision-making and can track key performance metrics to better identify opportunities for improvement.
Special thanks to the accreditation team and congratulations to all for making continuous improvement possible.
]]>It also emphasized the importance of a heart team in the care of patients receiving TAVR. At 黑料网 Medical Center, our heart team is committed to providing exceptional care to the people of North Carolina and beyond.
The memo cited 3 of our group’s papers in their decision:
Arora S, Misenheimer JA, Jones W, et al. Transcatheter versus surgical aortic valve replacement in intermediate risk patients: a meta-analysis. Cardiovascular Diagnosis and Therapy. 2016 Jun;6(3):241-9.
Arora S, Strassle PD, Ramm CJ, et al. Transcatheter versus surgical aortic valve replacement in patients with lower surgical risk scores: A systematic review and meta-analysis of early outcomes.聽 Heart, Lung and Circulation. 2017 Aug;26(8):840-845.
Arora S, Vaidya SR, Strassle PD, et al. Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement. Catheterizations and Cardiovascular Interventions: Official Journal of the Society of Cardiac Angiography and Interventions. 2018 Mar 1;91(4):806-812.
To read the full decision memo click .
]]>
]]>